BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6287872)

  • 1. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
    Warhol MJ; Hickey WF; Corson JM
    Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas.
    Jandik WR; Landas SK; Bray CK; Lager DJ
    Mod Pathol; 1993 Nov; 6(6):761-4. PubMed ID: 8302820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast.
    Warhol MJ; Corson JM
    Hum Pathol; 1985 Jan; 16(1):50-5. PubMed ID: 2982715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
    Dewar A; Valente M; Ring NP; Corrin B
    J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
    Blobel GA; Moll R; Franke WW; Kayser KW; Gould VE
    Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
    Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
    Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
    Ordóñez NG
    Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
    Sakuma N; Kamei T; Ishihara T
    Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
    O'Hara CJ; Corson JM; Pinkus GS; Stahel RA
    Am J Pathol; 1990 Feb; 136(2):421-8. PubMed ID: 2305835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
    Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
    J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinomas.
    Esteban JM; Sheibani K
    Mod Pathol; 1992 Nov; 5(6):626-30. PubMed ID: 1369798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural diagnostic problems of pleural tumors. A study of 125 cases (author's transl)].
    Stoebner P; Bernaudin JF; Adnet JJ; Basset F
    Rev Fr Mal Respir; 1979; 7(3):265-76. PubMed ID: 573917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
    Hammar SP; Bockus DE; Remington FL; Rohrbach KA
    Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ultrastructural pathology of malignant pleural mesothelioma.
    Coleman M; Henderson DW; Mukherjee TM
    Pathol Annu; 1989; 24 Pt 1():303-53. PubMed ID: 2654842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.